肌肉干细胞介导的T细胞免疫抑制的物种变异
Shisong Liu1, Pengbo Hou1, Weijia Zhang1
1The Fourth Affiliated Hospital of Soochow University, Institutes for Translational Medicine, State Key Laboratory of Radiation Medicine and Protection, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China.
Scientific reports
|October 8, 2024
概括
肌肉干细胞 (MuSCs) 显示出适应性免疫疾病的前景. 鼠标的MuSCs使用iNOS,而人类的MuSCs使用IDO进行免疫抑制,揭示了治疗开发的关键物种特异性差异.
科学领域:
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
背景情况:
- 肌肉干细胞 (MuSCs) 具有免疫调节特性,对先天性免疫疾病有益.
- 在适应性免疫驱动疾病中,MuSCs的疗效在很大程度上仍未被探索.
- 了解MuSC机制对于它们的治疗应用至关重要.
研究的目的:
- 研究 MuSCs在适应性免疫反应中的免疫调节能力.
- 阐明 MuSC 介导的 T 细胞抑制背后的特定物种机制.
- 评估MuSCs在T细胞介导的肝损伤中的治疗潜力.
主要方法:
- 在体外共同培养测定与细胞和外周血液单核细胞.
- 在对康卡纳瓦林A诱导的急性肝损伤的小鼠模型中,对小鼠和人类的MuSCs进行全身管理.
- 基因操纵 (删除/敲除) 和药理抑制可诱导的氧化合成酶 (iNOS) 和胺二氧化酶 (IDO) 在 MuSCs.
主要成果:
- 化MuSCs在体外有效抑制了T细胞的激活和增殖.
- 在小鼠中,给予MuSC改善了肝损伤病理.
- 鼠标MuSCs的免疫抑制依赖于可诱导的氧化合成酶 (iNOS),而人类MuSCs则依赖于胺2,3-二氧化酶 (IDO).
- 在小鼠MuSC中抑制iNOS或在人类MuSC中抑制iDO消除了它们的治疗效果.
结论:
- MuSCs对适应性免疫反应表现出强大的免疫抑制能力.
- 在MuSC免疫调节机制中存在显著的物种特异性差异,小鼠MuSC使用iNOS,人类MuSC使用IDO.
- 这些发现需要考虑物种特异性途径,以在免疫相关疾病中有效的基于MuSC的疗法.
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:40Cell-mediated Immune Responses
67.5K
Overview
67.5K
01:19Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
01:21Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
01:19Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K